Key Capital Corp (KCPC)

[Roily23]

So KCPC is about to be a total write off afer May 25 when brokerages stop allowing buys of CE stocks. Unless they have something up their sleeve I can't see them getting current in a month.

[ap17]

yup, relisting is what we need.

[pacman181]

All great news but its muted as until they get back on the exchange

[zforce]

Actually, years before Key Capital became involved in Crypto, they were focused on precious metals streaming...a royalty based model like Franco Nevada. Unfortunately that part of the business didn't prove very successful....at least not that I'm aware of. I've stayed around because of the cancer treatment and other work with Immunitor. Have not invested any money in any of their Crypto projects. I'm intrigued by Gold Crypto...but haven't seen enough evidence that they've got their to act together to participate. I've asked several times over the years if KCPC actually has any ongoing gold or silver streaming contracts...but never get an answer. I was thinking that would be the source of all the physical gold they've said would back Gold Crypto...but radio silence.

[Roily23]

I think everyone was in KCPC for the crypto and until one of these other ventures gets legs this is bound to be just another BS 0.00x stock.

[zforce]

Not a single mention on the board of Wednesday's press release. I guess I'll post it: https://finance.yahoo.com/news/key-capital-launches-maxcelllife-com-133000875.html

Jennifer Reilly appointed Marketing Director to Lead MaxCellLife.com LaunchNEW YORK, NY / ACCESSWIRE / April 7, 2021 / KEY CAPITAL CORPORATION (OTC PINK:KCPC) ...

[justbecause516]

Bauman has been on this from the start.For Key to garner a 15c211 is not going to be an easy task unless they have all the ducks in reality row.These days a firm has to worry about themselves and the expert market was created for situations like this one.Some company's do come back from the dead,but its not the rule.

[pacman181]

Interesting if they get it.. .''clinical trial strategy is being formulated with focus on the Immunitor V5 FDA Orphan Drug designated HCC candidate, up to US$30 million in development funding is being progressed with a number of interested parties through Key Biotec''

[pacman181]

Yeah, the news flow has been very consistent and professionally done.. future is very bright for Key..making all the right moves now

[ny3344]

Release: Key Capital to Focus on Oral Pill Cancer Treatment Success. https://www.streetinsider.com/Accesswire/Key+Capital+to+Focus+on+Oral+Pill+Cancer+Treatment+Success/18148019.html. Would be nice if all these announcements were happening with the stock trading normally. Hopefully in a month or two as has been suggested.

[pacman181]

I received an email from peter stating back on exchange April latest May...so im taking his word on that..they were getting new accountants and are completing the 19 &20 accounts

[ny3344]

That 33% drop was on a twenty dollar trade, most probably made by a market maker. Earlier, 5,000 shares went for .20. which would have represented a 566% gain for the day. Not that any of this matters until this stock resumes trading normally and on volume of at least 50-100,000 shares a day. Pacman181 thinks April. Hope he has inside info. Can't happen soon enough.

[ap17]

Agreed, but fail to understand the 33% drop on seemingly good news.

[pacman181]

There keeping the news flowing, i will give them that. .positive for the future here for a major upturn once back on the exchange..

[ny3344]

News: Key Capital to Launch M.Vaccae Supplement in Multi-Billion Anxiety, Stress and Depression Market. https://finance.yahoo.com/news/key-capital-launch-m-vaccae-150000026.html

[pacman181]

That should be sorted in April hopefully by then we will have a partner

[ap17]

AND a place to trade wouldn't hurt.

[pacman181]

Solid only if they can get it off the ground with serious partners or funding..

[ny3344]

News: Key Capital Leads Oral Pill Vaccines Race with Immunitor Partnering and Strong Patenting https://apnews.com/press-release/accesswire/business-technology-public-health-products-and-services-coronavirus-pandemic-55a3e67b396b6c0dd1009ac3f3f1180a

[pacman181]

If they can find the financing or a pharma partner this will be high reward

[ap17]

Key Capital COVID-19 Oral Pill Vaccine Records 90% Reduction in Virus Infectivity in Early Study

Monday, January 18, 2021 9:15 AM


Promising Safety Profile and 90% Reduction in Virus Infectivity Reported for Key Capital COVID-19 Oral Pill Therapeutic Vaccine

Would love to see a country pick this treatment.

[WinstonCup]

That would be nice!

[pacman181]

Back on the OTC by April latest May ..

[ap17]

Anyone know what became of the goldcrypto many of us bought, that kcpc handled?

[Schroe35]

Ohhh! It was. I was in wrong board. Let me find that Trump one. ????

[zforce]

I thought this was going to be a post on Trump's dancing.

[Schroe35]

Weird random movement.

[pacman181]

Once back on exchange,i expect big things here in the future . i will be a buyer definitely

[ArrowsOverAthens]

https://www.linkedin.com/in/peter-boonen-21112318

[ap17]

I know nothing about him.

[Schroe35]

What do we know about this Peter Boonen? Go a long ways in that “co-signer trust.” :)

[ap17]

Kinda like getting a co signer for a loan. The MM will be sticking out his neck far.

[pacman181]

Moving in right direction here..we will be back on exchange very soon

[Schroe35]

What are the challenges in getting a mm after a situation like theirs?

[ny3344]

Top priority. Other than making money.

[ap17]

Hope they get a MM to sign on, so we can get back on OTC again.

[ny3344]

New announcement today.
https://finance.yahoo.com/news/key-capital-distribute-novel-immune-153000297.html

[pacman181]

Needs the big money to recognise the potential to develop it and push for testing and rapid approval in US

[davidsson10]

Key Capital COVID-19 Oral Pill Vaccine Records 90% Reduction in Virus Infectivity in Early Study

Monday, January 18, 2021 9:15 AM


Promising Safety Profile and 90% Reduction in Virus Infectivity Reported for Key Capital COVID-19 Oral Pill Therapeutic Vaccine

NEW YORK, NY / ACCESSWIRE / January 18, 2021 / KEY CAPITAL CORPORATION (OTC PINK:KCPC) is pleased to advise that current independent laboratory testing of its partnered Immunitor COVID-19 patented oral pill vaccine in an ongoing university study is providing promising early support for safety and efficacy of the vaccine.

The preliminary tests conducted by a leading Asian research institute have shown safety and a 90% reduction on virus infectivity in mammalian cells following exposure to the active vaccine. This laboratory testing highlights the vaccine methodology and ability to inactivate and/or prevent viral infection and its potential for oral mucosal administration.

As varied injectable vaccines are being rushed into the major global markets, the virus continues to mutate and daily infections, hospitalizations, and deaths increase. Key Capital believes its COVID-19 oral pill therapeutic vaccine can potentially meet the pandemic challenges by being able to offer a much-needed therapeutic treatment option, as well as a highly efficient mass vaccination alternative.

Key Capital Corporation:

The Company's focus is on further development of its oral pill therapeutic vaccines within its Territory through its Key Biotec and Immunitor partnering; particularly on advancing the highly-promising FDA Orphan Drug Designated V5 liver cancer candidate.

Additionally, due to the unprecedented urgent global need for a simple, affordable, and easily mass distributable COVID-19 treatment and vaccine, the Company continues to explore the opportunity of securing funding partners, as well as other options.

For further information see: https://keybiotec.com and https://keycapitalcorp.com

For all inquiries please contact: Key Capital at [phone], or Peter Boonen, Chairman, at [e-mail]

References:

https://ycharts.com/indicators/us_coronavirus_hospitalizations

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=457714

https://pubmed.ncbi.nlm.nih.gov/28443252/

Disclaimer: Statements made in this press release that express the Company or management's intentions, plans, beliefs, expectations, or predictions of future events, are forward-looking statements. The words "believe," "expect," "intend," "estimate," "anticipate," "will" and similar expressions are intended to further identify such forward-looking statements, although not all forward-looking statements contain these identifying words. Those statements are based on many assumptions and are subject to many known and unknown risks, uncertainties and other factors that could cause the Company's actual activities, results or performance to differ materially from those anticipated or projected in such forward-looking statements. The Company cannot guarantee future financial results, levels of activity, performance or achievements and investors should not place undue reliance on the Company's forward-looking statements.

SOURCE: Key Capital Corporation

[pacman181]

Yeah received it, very encouraging. I got a couple emails from him last week, really high potential here, all about getting financing to progress..should be back on otc very soon.

[zforce]

New email from KCPC Mail List!
If you haven't clicked on the link at the top of the message board to get on the mail list. An email arrived from Peter Boonen this morning. Very hopeful sounding. It said "Click Here to View in Browser". So I'm hoping the resulting link works: https://mailchi.mp/5ac33f3f3018/welcome-to-key-capital-2021?e=f5b08a0bdc

[pacman181]

Nice to see they picked up Bauman, very encouraging and very experienced in OTC.they are involved with alot of shell and rever merger companies ..im am actually hopeful of very strong future here ..they are starting to step up here.

[Lalo2020]

Yup you're right. I've noticed they picked up another securities counsel. Now they have two. Bauman & Associates Law Firm, 6440 Sky Pointe Dr.Suite 140-149 Las Vegas, NV 89131 and Bart & Associates, LLC 1213 Culbreth Drive
Wilmington, NC 28405. This was written in their November press release " Regarding the current trading situation of the Company’s securities, the Company will be working with its advisors to ensure reinstatement of trading is resumed within the next six months." They have a new website-https://keycapitalcorp.com/

[ap17]

Hopefully they can get back to OTC so B/A trades can begin again. Need a MM to sign off.

[Lalo2020]

Lol well aint that some shit I hope they're attempting something been in this one over a year maybe a little more than 2 years now. Wasn't paying attention when it delisted and I'm still here same position haha. Waiting game now. But some activity to me brings a little joy.

[ap17]

It was a similar PR that got them booted from OTC scam land market to begin with.

[Lalo2020]

I'm sure they have gotten some type of reaction. Everyone is in a race to have the cure or medical solution for covid-19. Every company is gonna claim their solution works better than the other. Since Moderna lost court case to Arbutus over the technology used to create vaccine I'm sure has given confidence to other companies that the race to a solution for covid-19 is still open. So that court case probably doesn't help phefzer either I'm sure because they use that same patented and licensed Mrna technology used in the vaccine Owned by Arbutus.

[ap17]

While those numbers look amazing, we need volume to mean anything. Just 1/4 of my holdings would send this to trips if I place a sell order. THREE PLACES RIGHT OF THE PIMPLE.

[Roily23]

It's jumped before on 100 share total volumn. They issued a similar BS PR back in the start of the figgin CV19 epoch. I got here for Gold Secure and Cryto Secure and we know where that got us. Good luck.

[zforce]

As wonderful as it was to see my Roth 401k jump a whole lot today, I treated it as a mirage because with the low volume and the SEC suspension I knew it was just a fleeting thing.